Serum levels of CEA and CA 15-3 in triple-negative breast cancer at the time of diagnosis

By Dede Didem  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1429-1429

Humana Press, Inc

Access to resources Recommend Favorite

Prognostic role of serum CA15.3 in 362 node-negative breast cancers. An old player for a new game

By Gion M.   Boracchi P.   Dittadi R.   Biganzoli E.   Peloso L.   Mione R.   Gatti C.   Paccagnella A.   Marubini E.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1181-1188

Elsevier

Access to resources Recommend Favorite

CEA, MCA, CA 15.3 and CA 549 and Their Combinations in Expressing and Monitoring Metastatic Breast Cancer: a Prospective Comparative Study

By Martoni A.   Zamagni C.   Bellanova B.   Zanichelli L.   Vecchi F.   Cacciari N.   Strocchi E.   Pannuti F.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1615-1621

Elsevier

Access to resources Recommend Favorite

Prognostic Value of CEA and CA 19-9 Tumor Markers Combined with Cytology from Peritoneal Fluid in Colorectal Cancer

By Lee In  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 861-870

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer

By Wu Shih-Chung  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 879-882

Springer Publishing Company

Access to resources Recommend Favorite